Finland· FI-REL-REL3689
Alomide
A lodoxamide product containing lodoxamide tromethamine, registered in Finland by Novartis Finland Oy. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Lodoxamide is registered in 4 of 19 countries.
Countries holding a registration under ATC S01GX05 (lodoxamide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Lodoxamide · ATC S01GX05
4 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Lodoxamide tromethamine
- Manufacturer
- Novartis Finland Oy
- Country
- Finland (FI)
- ATC code
- S01GX05
- ATC class
- Lodoxamide
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lodoxamide in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAlomide 0.1% eye dropsDowelhurst Ltd
- BelgiumAlomide 1.78 mg/mlNovartis Pharma
- CanadaALOMIDENOVARTIS PHARMACEUTICALS CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Alomide
- United Kingdom (Northern Ireland) · Alomide
- Hungary · Alomide
- Luxembourg · Alomide
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4b52689-ca5e-4c3c-8fa7-a26aa68a437c GET /v1/drugs/d4b52689-ca5e-4c3c-8fa7-a26aa68a437c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "silmätipat, liuos",
"route": "Silmän pinnalle",
"ddd_unit": null,
"strength": "1 mg/ml",
"atc_label": "lodoksamidi",
"ma_number": "12107",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL3689",
"authorised_at": "1996-04-29"
}See everything about lodoxamide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.